- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Journal of Cancer Epidemiology
Volume 2013 (2013), Article ID 823849, 12 pages
Serum Lipid Profiles and Cancer Risk in the Context of Obesity: Four Meta-Analyses
1Cancer Epidemiology Group, Division of Cancer Studies, King’s College London, School of Medicine, 3rd Floor, Bermondsey Wing, Guy’s Hospital, London SE1 9RT, UK
2Regional Cancer Centre, Uppsala University Hospital, 751 85 Uppsala, Sweden
3Department of Surgical Sciences, Uppsala University, 751 85 Uppsala, Sweden
4Department of Epidemiology and Prevention of Cancer, Institute of Social and Preventative Medicine, University of Zurich, 8001 Zurich, Switzerland
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA
6Department of Pathology, Brigham and Women’s Hospital of Harvard Medical School, Boston, MA 02115, USA
7Broad Institute of Harvard and MIT, 7 Cambridge Center, Cambridge, MA 02142, USA
8Division of Cancer Studies, School of Medicine, King’s College London, 3rd Floor, Bermondsey Wing, Guy’s Hospital, London SE1 9RT, UK
Received 16 August 2012; Revised 26 October 2012; Accepted 2 November 2012
Academic Editor: Thomas E. Rohan
Copyright © 2013 Jennifer C. Melvin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- S. M. Grundy, “Metabolic complications of obesity,” Endocrine, vol. 13, no. 2, pp. 155–165, 2000.
- S. H. Jee, H. J. Kim, and J. Lee, “Obesity, insulin resistance and cancer risk,” Yonsei Medical Journal, vol. 46, no. 4, pp. 449–455, 2005.
- R. T. Jung, “Obesity as a disease,” British Medical Bulletin, vol. 53, no. 2, pp. 307–321, 1997.
- J. R. Pender and W. J. Pories, “Epidemiology of obesity in the United States,” Gastroenterology Clinics of North America, vol. 34, no. 1, pp. 1–7, 2005.
- V. J. Lawrence and P. G. Kopelman, “Medical consequences of obesity,” Clinics in Dermatology, vol. 22, no. 4, pp. 296–302, 2004.
- H. Vainio, R. Kaaks, and F. Bianchini, “Weight control and physical activity in cancer prevention: international evaluation of the evidence,” European Journal of Cancer Prevention, vol. 11, no. 2, pp. S94–S100, 2002.
- A. G. Renehan, M. Tyson, M. Egger, R. F. Heller, and M. Zwahlen, “Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies,” The Lancet, vol. 371, no. 9612, pp. 569–578, 2008.
- S. D. H. Malnick and H. Knobler, “The medical complications of obesity,” QJM, vol. 99, no. 9, pp. 565–579, 2006.
- A. A. Arslan, K. J. Helzlsouer, C. Kooperberg et al., “Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan),” Archives of Internal Medicine, vol. 170, no. 9, pp. 791–802, 2010.
- T. B. Van Itallie, “Obesity: adverse effects on health and longevity,” American Journal of Clinical Nutrition, vol. 32, no. 12, pp. 2723–2733, 1979.
- A. Vrieling, K. Buck, R. Kaaks, and J. Chang-Claude, “Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis,” Breast Cancer Research and Treatment, vol. 123, no. 3, pp. 641–649, 2010.
- D. Saunders, D. Seidel, M. Allison, and G. Lyratzopoulos, “Systematic review: the association between obesity and hepatocellular carcinoma—epidemiological evidence,” Alimentary Pharmacology and Therapeutics, vol. 31, no. 10, pp. 1051–1063, 2010.
- B. F. Fuemmeler, M. K. Pendzich, and K. P. Tercyak, “Weight, dietary behavior, and physical activity in childhood and adolescence: implications for adult cancer risk,” Obesity Facts, vol. 2, no. 3, pp. 179–186, 2009.
- D. J. Harriss, G. Atkinson, K. George et al., “Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index,” Colorectal Disease, vol. 11, no. 6, pp. 547–563, 2009.
- Z. Dai, Y. C. Xu, and L. Niu, “Obesity and colorectal cancer risk: a meta-analysis of cohort studies,” World Journal of Gastroenterology, vol. 13, no. 31, pp. 4199–4206, 2007.
- S. C. Larsson and A. Wolk, “Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies,” American Journal of Clinical Nutrition, vol. 86, no. 3, pp. 556–565, 2007.
- Y. Qian and J. G. Fan, “Obesity, fatty liver and liver cancer,” Hepatobiliary & Pancreatic Diseases International, vol. 4, no. 2, pp. 173–177, 2005.
- D. Leroith, R. Novosyadlyy, E. J. Gallagher et al., “Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence,” Experimental and Clinical Endocrinology and Diabetes, vol. 116, no. 1, pp. S4–S6, 2008.
- M. J. Khandekar, P. Cohen, and B. M. Spiegelman, “Molecular mechanisms of cancer development in obesity,” Nature Reviews Cancer, vol. 11, no. 12, pp. 886–895, 2011.
- P. J. Meikle and M. J. Christopher, “Lipidomics is providing new insight into the metabolic syndrome and its sequelae,” Current Opinion in Lipidology, vol. 22, no. 3, pp. 210–215, 2011.
- M. Tanasescu, M. F. Leitzmann, E. B. Rimm, and F. B. Hu, “Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes,” Circulation, vol. 107, no. 19, pp. 2435–2439, 2003.
- T. M. Manini, J. E. Everhart, K. V. Patel et al., “Daily activity energy expenditure and mortality among older adults,” Journal of the American Medical Association, vol. 296, no. 2, pp. 171–179, 2006.
- E. W. Gregg, J. A. Cauley, K. Stone et al., “Relationship of changes in physical activity and mortality among older women,” Journal of the American Medical Association, vol. 289, no. 18, pp. 2379–2386, 2003.
- P. J. Elmer, E. Obarzanek, W. M. Vollmer et al., “Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-Month results of a randomized trial,” Annals of Internal Medicine, vol. 144, no. 7, pp. 485–495, 2006.
- J. A. Meyerhardt, E. L. Giovannucci, S. Ogino et al., “Physical activity and male colorectal cancer survival,” Archives of Internal Medicine, vol. 169, no. 22, pp. 2102–2108, 2009.
- A. McTiernan, M. Irwin, and V. VonGruenigen, “Weight, physical activity, diet, and prognosis in breast and gynecologic cancers,” Journal of Clinical Oncology, vol. 28, no. 26, pp. 4074–4080, 2010.
- J. A. Ligibel, A. Giobbie-Hurder, D. Olenczuk et al., “Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors,” Cancer Causes & Control, vol. 20, no. 8, pp. 1523–1528, 2009.
- J. A. Ligibel, N. Campbell, A. Partridge et al., “Impact of a mixed strength and endurance exercise intervention on insulin levels in breast cancer survivors,” Journal of Clinical Oncology, vol. 26, no. 6, pp. 907–912, 2008.
- M. J. Gonyeau and D. W. Yuen, “A clinical review of statins and cancer: helpful or harmful?” Pharmacotherapy, vol. 30, no. 2, pp. 177–194, 2010.
- J. R. Emberson, P. M. Kearney, L. Blackwell, C. Newman, C. Reith, N. Bhala, et al., “Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy,” PloS One, vol. 7, no. 1, Article ID e29849, 2012.
- A. D. Mooradian, M. J. Haas, K. R. Wehmeier, and N. C. W. Wong, “Obesity-related changes in high-density lipoprotein metabolism,” Obesity, vol. 16, no. 6, pp. 1152–1160, 2008.
- H. Jafri, A. A. Alsheikh-Ali, and R. H. Karas, “Baseline and On-treatment high-density lipoprotein cholesterol and the risk of cancer in randomized controlled trials of lipid-altering therapy,” Journal of the American College of Cardiology, vol. 55, no. 25, pp. 2846–2854, 2010.
- D. E. Kok, J. G. van Roermund, K. K. Aben, M. den Heijer, D. W. Swinkels, E. Kampman, et al., “Blood lipid levels and prostate cancer risk, a cohort study,” Prostate Cancer and Prostatic Diseases, vol. 14, no. 4, pp. 340–345, 2011.
- D. McAuley, “Conventional Units—International Units,” 1993, http://www.globalrph.com/conv_si.htm.
- I. Jungner, G. Walldius, I. Holme, W. Kolar, and E. Steiner, “Apolipoprotein B and A-I in relation to serum cholesterol and triglycerides in 43 000 Swedish males and females,” International Journal of Clinical & Laboratory Research, vol. 21, no. 2-4, pp. 247–255, 1992.
- M. G. Shlipak, R. Katz, B. Kestenbaum et al., “Rate of kidney function decline in older adults: a comparison using creatinine and cystatin C,” American Journal of Nephrology, vol. 30, no. 3, pp. 171–178, 2009.
- J. Millan, X. Pinto, A. Munoz, M. Zuniga, J. Rubies-Prat, L. F. Pallardo, et al., “Lipoprotein ratios: physiological significance and clinical usefulness in cardiovascular prevention,” Vascular Health and Risk Management, vol. 5, pp. 757–765, 2009.
- J. I. Cleeman, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001.
- J. Ahn, U. Lim, S. J. Weinstein et al., “Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 11, pp. 2814–2821, 2009.
- J. J. Deeks, D. G. Altman, and M. J. Bradburn, “Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta-Analysis,” in Systematic Reviews in Health Care: Meta-Analysis in Context, M. Egger, G. D. Smith, and D. G. Altman, Eds., Chapter 15, BMJ Publishing, London, UK, 2008.
- J. V. Swinnen, H. Heemers, T. Van De Sande et al., “Androgens, lipogenesis and prostate cancer,” Journal of Steroid Biochemistry and Molecular Biology, vol. 92, no. 4, pp. 273–279, 2004.
- N. Mehta, J. Hordines, C. Volpe, R. Doerr, and S. A. Cohen, “Cellular effects of hypercholesterolemia in modulation of cancer growth and metastasis: a review of the evidence,” Surgical Oncology, vol. 6, no. 3, pp. 179–185, 1997.
- R. M. Arliss and C. A. Biermann, “Do soy isoflavones lower cholesterol, inhibit atherosclerosis, and play a role in cancer prevention?” Holistic Nursing Practice, vol. 16, no. 5, pp. 40–48, 2002.
- M. Mutoh, T. Akasu, M. Takahashi et al., “Possible involvement of hyperlipidemia in increasing risk of colorectal tumor development in human familial adenomatous polyposis,” Japanese Journal of Clinical Oncology, vol. 36, no. 3, pp. 166–171, 2006.
- R. Flavin, G. Zadra, and M. Loda, “Metabolic alterations and targeted therapies in prostate cancer,” Journal of Pathology, vol. 223, no. 2, pp. 283–294, 2011.
- O. Micheau, E. Solary, A. Hammann, F. Martin, and M. T. Dimanche-Boitrel, “Sensitization of cancer cells treated with cytotoxic drugs to fas- mediated cytotoxicity,” Journal of the National Cancer Institute, vol. 89, no. 11, pp. 783–789, 1997.
- T. Migita, S. Ruiz, A. Fornari et al., “Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer,” Journal of the National Cancer Institute, vol. 101, no. 7, pp. 519–532, 2009.
- S. Rossi, E. Graner, P. Febbo et al., “Fatty acid synthase expression defines distinct molecular signatures in prostate cancer,” Molecular Cancer Research, vol. 1, no. 10, pp. 707–715, 2003.
- Y. Kimura and M. Sumiyoshi, “High-fat, high-sucrose, and high-cholesterol diets accelerate tumor growth and metastasis in tumor-bearing mice,” Nutrition and Cancer, vol. 59, no. 2, pp. 207–216, 2007.
- M. Brown, C. Hart, T. Tawadros, V. Ramani, V. Sangar, M. Lau, et al., “The differential effects of statins on the metastatic behaviour of prostate cancer,” British Journal of Cancer, vol. 106, no. 10, pp. 1689–1696, 2012.
- Y. Yasuda, M. Shimizu, Y. Shirakami et al., “Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice,” Cancer Science, vol. 101, no. 7, pp. 1701–1707, 2010.
- E. J. Jacobs and S. M. Gapstur, “Cholesterol and cancer: answers and new questions,” Cancer Epidemiology Biomarkers and Prevention, vol. 18, no. 11, pp. 2805–2806, 2009.
- L. Calabresi, G. Rossoni, M. Gomaraschi, F. Sisto, F. Berti, and G. Franceschini, “High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-α content and enhancing prostaglandin release,” Circulation Research, vol. 92, no. 3, pp. 330–337, 2003.
- C. Pichard, G. Plu-Bureau, M. Neves-e Castro, and A. Gompel, “Insulin resistance, obesity and breast cancer risk,” Maturitas, vol. 60, no. 1, pp. 19–30, 2008.
- B. Adderley-Kelly and E. Williams-Stephens, “The relationship between obesity and breast cancer,” The ABNF Journal, vol. 14, no. 3, pp. 61–65, 2003.
- J. B. Barnett, “The relationship between obesity and breast cancer risk and mortality,” Nutrition Reviews, vol. 61, no. 2, pp. 73–76, 2003.
- R. Kaaks, A. Lukanova, and M. S. Kurzer, “Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review,” Cancer Epidemiology Biomarkers and Prevention, vol. 11, no. 12, pp. 1531–1543, 2002.
- P. M. Bracci, “Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms,” Molecular Carcinogenesis, vol. 51, no. 1, pp. 53–63, 2012.
- L. Jiao, A. Berrington de Gonzalez, P. Hartge, R. M. Pfeiffer, Y. Park, D. M. Freedman, et al., “Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts,” Cancer Causes & Control, vol. 21, no. 8, pp. 1305–1314, 2010.
- A. B. De Gonzalez, S. Sweetland, and E. Spencer, “A meta-analysis of obesity and the risk of pancreatic cancer,” British Journal of Cancer, vol. 89, no. 3, pp. 519–523, 2003.
- M. A. Moyad, “Is obesity a risk factor for prostate cancer, and does it even matter? A hypothesis and different perspective,” Urology, vol. 59, no. 4, pp. 41–50, 2002.
- “Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia,” Report of A WHO/IDF Consulation, World Health Organisation, Geneva, Switzerland, 2006.
- M. Inoue, M. Noda, N. Kurahashi et al., “Impact of metabolic factors on subsequent cancer risk: results from a large-scale population-based cohort study in Japan,” European Journal of Cancer Prevention, vol. 18, no. 3, pp. 240–247, 2009.
- H. Iso, A. Ikeda, M. Inoue, S. Sato, and S. Tsugane, “Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts,” International Journal of Cancer, vol. 125, no. 11, pp. 2679–2686, 2009.
- C. M. Kitahara, A. B. De González, N. D. Freedman et al., “Total cholesterol and cancer risk in a large prospective study in Korea,” Journal of Clinical Oncology, vol. 29, no. 12, pp. 1592–1598, 2011.
- A. G. Mainous III, B. J. Wells, R. J. Koopman, C. J. Everett, and J. M. Gill, “Iron, lipids, and risk of cancer in the Framingham offspring cohort,” American Journal of Epidemiology, vol. 161, no. 12, pp. 1115–1122, 2005.
- J. C. Melvin, D. Seth, L. Holmberg, et al., “Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study,” Cancer Epidemiology, Biomarkers & Prevention, vol. 21, no. 8, pp. 1381–1384, 2012.
- S. J. Chang, M. F. Hou, S. M. Tsai et al., “The association between lipid profiles and breast cancer among Taiwanese women,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 9, pp. 1219–1223, 2007.
- A. S. Furberg, M. B. Veierød, T. Wilsgaard, L. Berstein, and I. Thune, “Serum high density lipoprotein cholesterol, metabolic profile, and breast cancer risk,” Journal of the National Cancer Institute, vol. 96, no. 15, pp. 1152–1160, 2004.
- M. Ha, J. Sung, and Y. M. Song, “Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women,” Cancer Causes & Control, vol. 20, no. 7, pp. 1055–1060, 2009.
- N. Hayashi, M. Matsushima, T. Yamamoto, H. Sasaki, H. Takahashi, and S. Egawa, “The impact of hypertriglyceridemia on prostate cancer development in patients aged ≥60 years,” BJU International, vol. 109, no. 4, pp. 515–519, 2012.
- J. A. Kaye, C. R. Meier, A. M. Walker, and H. Jick, “Statin use, hyperlipidaemia, and the risk of breast cancer,” British Journal of Cancer, vol. 86, no. 9, pp. 1436–1439, 2002.
- Y. Kim, S. K. Park, W. Han et al., “Serum high-density lipoprotein cholesterol and breast cancer risk by menopausal status, body mass index, and hormonal receptor in Korea,” Cancer Epidemiology Biomarkers & Prevention, vol. 18, no. 2, pp. 508–515, 2009.
- K. Lindemann, L. J. Vatten, M. Ellstrøm-Engh, and A. Eskild, “Serum lipids and endometrial cancer risk: results from the HUNT-II study,” International Journal of Cancer, vol. 124, no. 12, pp. 2938–2941, 2009.
- A. E. Cust, R. Kaaks, C. Friedenreich et al., “Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC),” Endocrine-Related Cancer, vol. 14, no. 3, pp. 755–767, 2007.
- D. Seth, H. Garmo, A. Wigertz, et al., “Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study,” International Journal of Molecular Epidemiology and Genetics, vol. 3, no. 2, pp. 122–133, 2012.
- L. Magura, R. Blanchard, B. Hope, J. R. Beal, G. G. Schwartz, and A. E. Sahmoun, “Hypercholesterolemia and prostate cancer: a hospital-based case-control study,” Cancer Causes & Control, vol. 19, no. 10, pp. 1259–1266, 2008.
- A. M. Mondul, S. L. Clipp, K. J. Helzlsouer, and E. A. Platz, “Association between plasma total cholesterol concentration and incident prostate cancer in the CLUE II cohort,” Cancer Causes and Control, vol. 21, no. 1, pp. 61–68, 2010.
- A. M. Mondul, S. J. Weinstein, J. Virtamo, and D. Albanes, “Serum total and HDL cholesterol and risk of prostate cancer,” Cancer Causes & Control, vol. 22, no. 11, pp. 1545–1552, 2011.
- E. A. Platz, C. Till, P. J. Goodman et al., “Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial,” Cancer Epidemiology Biomarkers & Prevention, vol. 18, no. 11, pp. 2807–2813, 2009.
- M. Van Hemelrijck, G. Walldius, I. Jungner et al., “Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study,” Cancer Causes & Control, vol. 22, no. 7, pp. 1011–1019, 2011.
- M. Van Hemelrijck, H. Garmo, L. Holmberg et al., “Prostate cancer risk in the Swedish AMORIS study,” Cancer, vol. 117, no. 10, pp. 2086–2095, 2011.
- F. Bravi, L. Scotti, C. Bosetti et al., “Self-reported history of hypercholesterolaemia and gallstones and the risk of prostate cancer,” Annals of Oncology, vol. 17, no. 6, pp. 1014–1017, 2006.
- M. Tsushima, A. M. Y. Nomura, J. Lee, and G. N. Stemmermann, “Prospective study of the association of serum triglyceride and glucose with colorectal cancer,” Digestive Diseases and Sciences, vol. 50, no. 3, pp. 499–505, 2005.
- F. J. van Duijnhoven, H. B. Bueno-De-Mesquita, M. Calligaro, et al., “Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition,” Gut, vol. 60, no. 8, pp. 1094–1102, 2011.
- Y. W. Chung, D. S. Han, Y. K. Park et al., “Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea,” Digestive and Liver Disease, vol. 38, no. 9, pp. 668–672, 2006.
- M. Van Hemelrijck, H. Garmo, N. Hammar et al., “The interplay between lipid profiles, glucose, BMI and risk of kidney cancer in the Swedish AMORIS study,” International Journal of Cancer, vol. 130, no. 9, pp. 2118–2128, 2012.
- G. Andreotti, J. Chen, Y.-T. Gao et al., “Serum lipid levels and the risk of biliary tract cancers and biliary stones: A population-based study in China,” International Journal of Cancer, vol. 122, no. 10, pp. 2322–2329, 2008.
- K. Asano, M. Kubo, K. Yonemoto et al., “Impact of serum total cholesterol on the incidence of gastric cancer in a population-based prospective study: the Hisayama study,” International Journal of Cancer, vol. 122, no. 4, pp. 909–914, 2008.